Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries

Effective and durable options for infrapopliteal artery revascularization for patients with chronic limb-threatening ischemia (CLTI) are limited. The SAVAL trial is a prospective, multicenter, randomized trial of patients with CLTI and infrapopliteal artery lesions with total lesion length ⩽ 140 mm,...

Full description

Saved in:

Bibliographic Details
Published in:	Vascular medicine (London, England) Vol. 28; no. 6; p. 571
Main Authors:	van Overhagen, Hans, Nakamura, Masato, Geraghty, Patrick J, Rao, Sid, Arroyo, Max, Soga, Yoshimitsu, Iida, Osamu, Armstrong, Ehrin, Nakama, Tatsuya, Fujihara, Masahiko, Ansari, Mohammad M, Mathews, Santhosh J, Gouëffic, Yann, Jaff, Michael R, Weinberg, Ido, Pinto, Duane S, Ohura, Norihiko, Couch, Kara, Mustapha, Jihad A
Format:	Journal Article
Language:	English
Published:	England 01.12.2023
Subjects:	Angioplasty, Balloon - adverse effects Drug-Eluting Stents - adverse effects Humans Ischemia - diagnostic imaging Ischemia - therapy Paclitaxel - adverse effects Peripheral Arterial Disease - diagnostic imaging Peripheral Arterial Disease - therapy Popliteal Artery - diagnostic imaging Prospective Studies Stents Treatment Outcome Vascular Patency stent chronic limb-threatening ischemia (CLTI) endovascular therapy peripheral artery disease (PAD)
ISSN:	1477-0377, 1477-0377
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!